NeuroSolutions has established expertise in delivering first class preclinical translational research

NeuroSolutions is a contract research organisation established in 2001 as a service provider of cutting edge electrophysiological and behavioural research in the field of neuroscience.

Publications
Posters

Neurodegeneration

NeuroSolutions has extensive experience in delivering first class preclinical translational research into the study, treatment and prevention of neurodegenerative disorders, particularly around amyloid based animal models of Alzheimer’s disease.

Our track record is demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs.

Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs.


Relevant NeuroSolutions Publications:

Disease Areas Behavioural Tests Electrophysiological Assays
Disease Areas
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Huntington’s Disease
Behavioural Tests
  • Open field: e.g. object recognition test (ORT), Y-maze, Barnes maze
  • Operant chambers: e.g. Alternating Lever Cyclic Ratio (ALCR), delayed match-to-position (DMTP/DNMTP)
  • Beta-amyloid induced deficits (ADDL/APP/oligomers/aggregated) α-synuclein-induced deficits
  • Commercially available transgenic rodent models
Behavioural Tests

In vivo: single cells – extra and intracellular recording; iontophoretic, central and parenteral drug administration

Local field potentials – spontaneous and evoked, including LTP/LTD

Peripheral nerves – compound and single fibre

Telemetric and multi-electrode recording

In vitro: whole-cell patch-clamp recordings from brain slices (current/voltage/blind/visualised)

Local field potentials – spontaneous and evoked extracellular recordings from brain slices, including LTP/LTD and multi-electrode recording (MEA)

Ion channel pharmacology – state-dependency, kinetics, and site of action using cultured and primary dissociated neurones, cell lines

 

"Thank you for the absolutely phenomenal work you have done for Redpin. As biotech managers, we frequently push CROs to the max and sometimes take them for granted. After reviewing the work that you have done over the past year, I felt that I needed to let you know what a difference you had made to Redpin’s growth and success. Your work has been of the highest caliber and your dedication unmatched."

Elma Hawkins PhD, MBA, former President and CEO Redpin Therapeutics, Inc.

"I have worked with NeuroSolutions on many projects over many years. The quality of the data is second to none, their scientific expertise and collaborative approach to our technicality demanding projects has been excellent. For example, the work on SEN1576 has led to high-impact joint publications with Senexis and this compound is now being developed by Talisman Therapeutics.."

Dr Mark Treherne - As former Chief Executive of Senexis Limited (Dr Treherne is currently Chief Executive of Life Sciences Organisation at UK Trade & Investment, which helps UK business trade overseas).

In partnership with
Science Exchange
Pacific Discovery Services
scientist.com
NeuroSolutions Ltd

Email: info@nsolns.com
Contact Head-office on +44 (0) 8454 500171


One of our partner companies may be better suited to your requirements

AUSTRALASIA
Pacific Discovery Services

Email: info@pacificdiscoveryservices.com